The authors confirmed essential roles for VIM and SFRP2 in important signaling pathways such as growth, proliferation, invasiveness, epithelial to mesynchymal (EMT) phenotype and stemness, using CTCs of CRC patients. This evidence concerns the gene SFRP2 and colorectal carcinoma.